143 related articles for article (PubMed ID: 15168806)
1. Epstein-Barr virus viral load in Crohn's disease: effect of immunosuppressive therapy.
Reijasse D; Le Pendeven C; Cosnes J; Dehee A; Gendre JP; Nicolas JC; Beaugerie L
Inflamm Bowel Dis; 2004 Mar; 10(2):85-90. PubMed ID: 15168806
[TBL] [Abstract][Full Text] [Related]
2. Seroprevalence of Epstein-Barr Virus, Cytomegalovirus, and Polyomaviruses in Children with Inflammatory Bowel Disease.
Hradsky O; Copova I; Zarubova K; Durilova M; Nevoral J; Maminak M; Hubacek P; Bronsky J
Dig Dis Sci; 2015 Nov; 60(11):3399-407. PubMed ID: 26091801
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus-associated lymphoma in Crohn's disease.
Losco A; Gianelli U; Cassani B; Baldini L; Conte D; Basilisco G
Inflamm Bowel Dis; 2004 Jul; 10(4):425-9. PubMed ID: 15475752
[TBL] [Abstract][Full Text] [Related]
4. [Epstein Barr viral load monitoring in mononuclear lymphocytes and serum of renal transplant recipients using a quantitative PCR protocol].
Merlino C; Giacchino F; Bergallo M; Bonello F; Bollero C; Segoloni GP; Cavallo R
G Ital Nefrol; 2003; 20(2):170-5. PubMed ID: 12746803
[TBL] [Abstract][Full Text] [Related]
5. Epstein Barr virus-positive mucocutaneous ulcer of the colon associated Hodgkin lymphoma in Crohn's disease.
Moran NR; Webster B; Lee KM; Trotman J; Kwan YL; Napoli J; Leong RW
World J Gastroenterol; 2015 May; 21(19):6072-6. PubMed ID: 26019475
[TBL] [Abstract][Full Text] [Related]
6. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy.
Colombel JF; Loftus EV; Tremaine WJ; Pemberton JH; Wolff BG; Young-Fadok T; Harmsen WS; Schleck CD; Sandborn WJ
Am J Gastroenterol; 2004 May; 99(5):878-83. PubMed ID: 15128354
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus load in whole blood is associated with immunosuppression, but not with post-transplant lymphoproliferative disease in stable adult heart transplant patients.
Doesch AO; Konstandin M; Celik S; Kristen A; Frankenstein L; Sack FU; Schnabel P; Schnitzler P; Katus HA; Dengler TJ
Transpl Int; 2008 Oct; 21(10):963-71. PubMed ID: 18564989
[TBL] [Abstract][Full Text] [Related]
8. Infliximab and the risk of latent viruses reactivation in active Crohn's disease.
Lavagna A; Bergallo M; Daperno M; Sostegni R; Costa C; Leto R; Crocellà L; Molinaro G; Rocca R; Cavallo R; Pera A
Inflamm Bowel Dis; 2007 Jul; 13(7):896-902. PubMed ID: 17345605
[TBL] [Abstract][Full Text] [Related]
9. Long term treatment with abatacept or tocilizumab does not increase Epstein-Barr virus load in patients with rheumatoid arthritis - A three years retrospective study.
Balandraud N; Texier G; Massy E; Muis-Pistor O; Martin M; Auger I; Guzian MC; Guis S; Pham T; Roudier J
PLoS One; 2017; 12(2):e0171623. PubMed ID: 28199343
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics, outcome and the role of viral load in nontransplant patients with Epstein-Barr viraemia.
Martelius T; Lappalainen M; Aalto SM; Nihtinen A; Hedman K; Anttila VJ
Clin Microbiol Infect; 2010 Jun; 16(6):657-62. PubMed ID: 19694766
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of PCR results in the diagnosis of Epstein-Barr virus infections].
Karadağ Geçgel S; Ersoy A; Sevinir BB; Sınırtaş M; Göral G
Mikrobiyol Bul; 2012 Oct; 46(4):594-606. PubMed ID: 23188573
[TBL] [Abstract][Full Text] [Related]
12. Epstein Barr viral load monitoring by quantitative PCR in renal transplant patients.
Merlino C; Cavallo R; Bergallo M; Giacchino F; Bollero C; Negro Ponzi A; Cavallo G
New Microbiol; 2003 Apr; 26(2):141-9. PubMed ID: 12737195
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus in inflammatory bowel disease-correlation with different therapeutic regimens.
Magro F; Santos-Antunes J; Albuquerque A; Vilas-Boas F; Macedo GN; Nazareth N; Lopes S; Sobrinho-Simões J; Teixeira S; Dias CC; Cabral J; Sarmento A; Macedo G
Inflamm Bowel Dis; 2013 Jul; 19(8):1710-6. PubMed ID: 23574759
[TBL] [Abstract][Full Text] [Related]
14. Lymphoma and Epstein-Barr virus DNA in blood during interleukin-2 therapy in antiretroviral-naïve HIV-1-infected patients: a substudy of the ANRS 119 trial.
de Lastours V; LeGoff J; Brière J; Agbalika F; Boulet T; Lévy Y; Simon F; Aboulker JP; Molina JM
HIV Med; 2014 Jan; 15(1):23-9. PubMed ID: 24007426
[TBL] [Abstract][Full Text] [Related]
15. Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis.
Esteve M; Saro C; González-Huix F; Suarez F; Forné M; Viver JM
Gut; 2004 Sep; 53(9):1363-5. PubMed ID: 15306601
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulator-associated Epstein-Barr virus-positive mucocutaneous ulcer in a patient with refractory Crohn's disease.
Hamanaka S; Nakagawa T; Ota S; Iida M; Ohta Y; Isshiki Y; Kasamatsu S; Ishigami H; Taida T; Okimoto K; Saito K; Maruoka D; Matsumura T; Ohwada C; Takeuchi M; Sakaida E; Arai M; Katsuno T; Nakaseko C; Nakatani Y; Kato N
Clin J Gastroenterol; 2019 Aug; 12(4):330-335. PubMed ID: 30903514
[TBL] [Abstract][Full Text] [Related]
17. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
Schubert S; Renner C; Hammer M; Abdul-Khaliq H; Lehmkuhl HB; Berger F; Hetzer R; Reinke P
J Heart Lung Transplant; 2008 Jan; 27(1):100-5. PubMed ID: 18187094
[TBL] [Abstract][Full Text] [Related]
18. No increase in Epstein-Barr virus viral load in a group of 30 asymptomatic patients with Crohn's disease.
Fernandez Salazar L; Rojo S; De Lejarazu RO; Castro E; Higuera E; González JM
Am J Gastroenterol; 2013 Dec; 108(12):1933-5. PubMed ID: 24300873
[No Abstract] [Full Text] [Related]
19. Herpes zoster in Crohn's disease during treatment with infliximab.
Wang X; Zhao J; Zhu S; Xia B
Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):237-9. PubMed ID: 24216569
[TBL] [Abstract][Full Text] [Related]
20. Drug therapies and the risk of malignancy in Crohn's disease: results from the TREAT™ Registry.
Lichtenstein GR; Feagan BG; Cohen RD; Salzberg BA; Diamond RH; Langholff W; Londhe A; Sandborn WJ
Am J Gastroenterol; 2014 Feb; 109(2):212-23. PubMed ID: 24394749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
